Pharmaceutical company develops innovative treatments and eye drops for ocular surface diseases, specializing in dry eye conditions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Surface Ophthalmics is a pharmaceutical company dedicated to developing innovative treatments for ocular surface diseases, with a particular focus on dry eye syndrome. Their pipeline includes both prescription and over-the-counter eye drops, utilizing patented formulations designed to address various forms of dry eye and post-surgical ocular conditions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Surface Ophthalmics Management Team
Surface Ophthalmics Valuations & Financials
View real-time NPM data on Surface Ophthalmics stock including daily Surface Ophthalmics stock price estimates, valuation history, and historical share price information. Access Surface Ophthalmics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Surface Ophthalmics pricing across six independent market signals. Looking for private company due diligence data sources on Surface Ophthalmics? Get in touch to learn more.
Similar Companies
like Surface Ophthalmics
Fellow
Healthcare & Life Sciences
Delivers diagnostic semen analysis that processes mailed samples with AI‑backed validation and lab-grade accuracy.
Celea Therapeutics
Healthcare & Life Sciences
Biopharmaceutical company developing next-generation therapies for serious respiratory diseases.
Earli
Healthcare & Life Sciences
Forces cancer cells to produce a synthetic biomarker, enabling precise PET scan detection through gene therapy-based Synthetic Biopsy.
SCG Cell Therapy
Healthcare & Life Sciences
Develops immunotherapy treatments for chronic infections and cancers using T-cell receptor technology to enhance immune system response.
Differentiated Therapeutics
Healthcare & Life Sciences
Develops novel protein degrader therapeutics using an AI-driven platform to target and eliminate disease-causing proteins.
tab32
Healthcare & Life Sciences
Delivers a platform that manages dental operations, patient data, and billing while improving workflows and practice performance.
Lucem Health
Healthcare & Life Sciences
Delivers AI solutions that integrate with clinical workflows to identify high-risk, undertreated patients and enable earlier disease detection.
Scimar
Healthcare & Life Sciences
Biotech company develops innovative solutions for type-II diabetes prevention, detection and treatment while advancing metabolic health research.
InterVenn
Healthcare & Life Sciences
Delivers artificial intelligence-driven glycoproteomic analysis to accelerate early disease detection and clinical biomarker discovery for personalized medicine.
FAQ
We have answers
Surface Ophthalmics stock does not trade on public stock exchanges. Surface Ophthalmics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Surface Ophthalmics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Surface Ophthalmics Stock does not trade on public stock exchanges. In order to sell Surface Ophthalmics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Surface Ophthalmics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Surface Ophthalmics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Surface Ophthalmics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Surface Ophthalmics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Surface Ophthalmics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Surface Ophthalmics is a private company and has not had an IPO. There is currently no Surface Ophthalmics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Surface Ophthalmics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
